RWM
ADPT icon

Rialto Wealth Management’s Adaptive Biotechnologies ADPT Stock Holding History

Rialto Wealth Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14K Hold
53
– – ﹤0.01% 1320
2026
Q1 		$736 Hold
53
– – ﹤0.01% 1223
2025
Q4 		$861 Hold
53
– – ﹤0.01% 1051
2025
Q3 		$793 Hold
53
– – ﹤0.01% 1018
2025
Q2 		$618 Sell
53
-7
-12% -$64 ﹤0.01% 1046
2025
Q1 		$446 Buy
+60
New +$461 ﹤0.01% 944

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Rialto Wealth Management's ADPT Position: Q2 2026 in Review

Rialto Wealth Management held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 53 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #1320.

Rialto Wealth Management first reported a position in ADPT in Q1 2025 and has held it in 6 quarters since. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Rialto Wealth Management held 53 shares of Adaptive Biotechnologies worth $1.14K as of Q2 2026.
  • Rialto Wealth Management left its Adaptive Biotechnologies share count unchanged in Q2 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #1320 holding.
  • Rialto Wealth Management first reported a position in Adaptive Biotechnologies in Q1 2025 and has held it in 6 quarters since.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.